Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders??? Equity (Unaudited)

v3.21.2
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Total
Balance at Dec. 31, 2019 $ 1,384 $ 75,890,295 $ 152,803 $ (37,473,580) $ 38,570,902
Balance (in Shares) at Dec. 31, 2019 13,846,925        
Common stock issued for cash $ 1 72,499 72,500
Common stock issued for cash (in Shares) 12,292        
Shares issued upon exchange of common stock equivalents $ 41 (41)
Shares issued upon exchange of common stock equivalents (in Shares) 410,170        
Beneficial conversion feature on convertible debt issued   329,300 329,300
Net loss (2,381,260) (2,381,260)
Other comprehensive income (Loss) (1,844,205) (1,844,205)
Balance at Mar. 31, 2020 $ 1,426 76,292,053 (1,691,402) (39,854,840) 34,747,237
Balance (in Shares) at Mar. 31, 2020 14,269,387        
Balance at Dec. 31, 2020 $ 2,617 78,005,004 636,886 (48,357,638) 30,286,869
Balance (in Shares) at Dec. 31, 2020 26,171,225        
Shares issued upon conversion of KBL debt $ 47 1,941,078 1,941,125
Shares issued upon conversion of KBL debt (in Shares) 467,123        
Shares issued upon conversion of 180 debt $ 16 432,367 432,383
Shares issued upon conversion of 180 debt (in Shares) 158,383        
Shares issued in connection with the private offering, net of financing costs(a) [1] $ 256 10,730,814 10,731,070
Shares issued in connection with the private offering, net of financing costs(a) (in Shares) [1] 2,564,000        
Offering costs allocated to warrant liabilities [1] 604,118 604,118
Warrants issued in connection with the private offering, reclassified to derivative liabilities (7,294,836) (7,294,836)
Shares issued upon exchange of common stock equivalents $ 96 (96)
Shares issued upon exchange of common stock equivalents (in Shares) 959,809       959,809
Common stock $ 20 925,384 $ 925,404
Common stock (in Shares) 197,790        
Options 1,092,399 1,092,399
Net loss (16,198,585) (16,198,585)
Other comprehensive income (Loss) 189,348 189,348
Balance at Mar. 31, 2021 $ 3,052 $ 86,436,232 $ 826,234 $ (64,556,223) $ 22,709,295
Balance (in Shares) at Mar. 31, 2021 30,518,330        
[1] Consists of $11,700,000 of gross proceeds from the offering, net of placement agent fees and other cash offering costs of $968,930. Of the $968,930 offering costs, $364,812 was allocated to the common stock and $604,118 was allocated to the warrant liabilities and expensed immediately due to their liability classification (see Note 6 – Derivative Liabilities – Warrants Issued in Private Offering).